Dimerix Limited (ASX:DXB)

Revenue by Product

Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Biopharmaceutical Drugs	8.39M
Biopharmaceutical Drugs Growth	-6.58%

Revenue by Geography

Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Australia	8.39M
Australia Growth	-6.58%